Haleon (HLN) Interest & Investment Income (2021 - 2023)
Haleon (HLN) posted Interest & Investment Income of $47.2 million for Q4 2023, up 34.61% on a QoQ basis from $35.0 million in Q2 2023, and down 6.49% year-over-year from $50.4 million in Q4 2022.
Haleon (HLN) Interest & Investment Income (2021 - 2023) Analysis & Trends
Haleon's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $47.2 million for Q4 2023.
- Quarterly Interest & Investment Income fell 6.49% year-over-year to $47.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $144.9 million (changed N/A YoY) and the FY2025 annual result came in at $102.8 million, down 1.88% from the prior year.
- Interest & Investment Income was $47.2 million for Q4 2023 at Haleon, up from $35.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $52.9 million in Q3 2022 and bottomed at $12.2 million in Q2 2023.
- A 3-year average of $35.9 million and a median of $41.1 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 187.81% — and 2023, when it fell 6.49%.
- Haleon's Interest & Investment Income stood at $17.5 million in 2021, then jumped by 187.81% to $50.4 million in 2022, then dropped by 6.49% to $47.2 million in 2023.
- Business Quant data shows HLN's Interest & Investment Income at $47.2 million in Q4 2023, $35.0 million in Q2 2023, and $12.2 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 47.16 Mn |
| Jun 30, 2023 | 35.04 Mn |
| May 3, 2023 | 12.23 Mn |
| Dec 31, 2022 | 50.44 Mn |
| Sep 20, 2022 | 52.95 Mn |
| Dec 31, 2021 | 17.52 Mn |